H.R. 6227 · 118th Congress · 2023–2024
Adding Coccidioidomycosis to the FDA Priority Review Voucher Program Act of 2023
H.R. 6227 in the 118th Congress (2023–2024) was introduced on Nov 3, 2023, sponsored by David Schweikert with 35 co-sponsors.
During the 118th Congress (2023–2024), Joe Biden was president, and Republicans held the House majority and Democrats the Senate majority.
- Status
- Introduced
- Introduced
- Nov 3, 2023
- Co-sponsors
- 35
- Policy area
- Health
What it does
Adding Coccidioidomycosis to the FDA Priority Review Voucher Program Act of 2023 This bill expands the priority-review voucher program for tropical diseases to include coccidioidomycosis (also known as Valley fever). A voucher entitles the holder to have a future new drug or biological product application acted upon by the Food and Drug Administration within six months.
Summary by the nonpartisan Congressional Research Service.
Sponsor
David Schweikert (R-AZ). Co-sponsors: 14 Democrats, 21 Republicans.
Where it stands
- IntroducedNov 3, 2023
- Passed the House—
- Passed the Senate—
- Sent to the President—
- Became law—
Latest action: Referred to the Subcommittee on Health. (Nov 10, 2023)
More bills from David Schweikert in the 118th Congress
Other Health bills in the 118th Congress
- H.R. 2544: Securing the U.S. Organ Procurement and Transplantation Network Act
- H.R. 2365: National Plan to End Parkinson’s Act
- H.R. 4581: Maternal and Child Health Stillbirth Prevention Act of 2023
- S. 265: Supporting and Improving Rural EMS Needs Reauthorization Act
- S. 4351: Poison Control Centers Reauthorization Act of 2024
- S. 133: NAPA Reauthorization Act
- S. 134: Alzheimer’s Accountability and Investment Act
- H.R. 7189: Congenital Heart Futures Reauthorization Act of 2024
- H.R. 7218: BOLD Infrastructure for Alzheimer's Reauthorization Act of 2024
- H.R. 3821: Firefighter Cancer Registry Reauthorization Act of 2023
Committees
More
From GovInfo bill records, Congressional Research Service summaries, Voteview roll calls and lobbying reports.
Cite or embed this page
Capitol Receipts, “H.R. 6227 (118th Congress): Adding Coccidioidomycosis to the FDA…,” https://www.capitolreceipts.com/bill/118-hr-6227/adding-coccidioidomycosis-to-the-fda-priority-review-voucher-program (accessed 2026-10-17).